New echocardiographic indices of shift to biventricular failure to optimize risk stratification of chronic heart failure.
Echocardiography
Heart failure
Left atrial
Prognosis
Pulmonary pressure
Right ventricular
Journal
ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
revised:
01
11
2021
received:
08
11
2020
accepted:
06
11
2021
pubmed:
8
12
2021
medline:
26
3
2022
entrez:
7
12
2021
Statut:
ppublish
Résumé
The present study investigated the prognostic impact of either isolated left atrial (LA) impairment, or its association with right ventricular (RV) failure, in heart failure (HF) with reduced ejection fraction (HFrEF), using basic and speckle tracking echocardiography (STE). One hundred and six outpatients with HFrEF were enrolled in this prospective observational study. Patients with primary lung diseases, non-sinus rhythm, previous cardiac surgery, and poor acoustic window were excluded. After clinical examination and basic echocardiography, STE was used to measure peak atrial longitudinal strain (PALS) and a new marker of RV performance and pulmonary circulation relation: free-wall RV longitudinal strain (fwRVLS)/systolic pulmonary artery pressure (sPAP). Patients were followed for all-cause/cardiovascular death and HF hospitalization. Of 84 eligible patients (60.1 ± 11.5 years; 82% male patients), 48 reached the combined endpoint (cardiovascular death and/or HF hospitalization). Population was divided into three groups: Group 1 (PALS ≥ 15 and fwRVLS/sPAP ≤ -0.5), Group 2 (PALS ≤ 15 and fwRVLS/sPAP ≤ -0.5), and Group 3 (PALS ≤ 15 and fwRVLS/sPAP > -0.5). Mean follow up was 3.5 ± 0.3 years. The higher severity groups were associated with higher LA volume index (P < 0.0001), New York Heart Association class (P = 0.02), mitral regurgitation (P = 0.0004) and tricuspid regurgitation grades (P < 0.0001), lower left ventricular (LV) ejection fraction (P = 0.0003), LV global longitudinal strain (P < 0.0001), PALS (P < 0.0001), tricuspid annular plane systolic excursion (P < 0.007), sPAP (P < 0.0001), and RV strain (P < 0.0001). Reduced PALS and fwRVLS/sPAP were independent predictors of the combined endpoint with adjusted Cox models (hazard ratio = 9.54; 95% confidence interval = 2.95-30.92; P = 0.0002 for Group 3 vs. Group 1). Kaplan-Meier curves showed early and persistent divergence between the three groups for the prediction of the combined endpoint and of all-cause death (P < 0.0001). The combination of LA and right heart damage entails worse prognosis in patients with HFrEF. The evaluation of PALS and fwRVLS/sPAP could aid risk stratification of HFrEF patients to provide them early treatment.
Identifiants
pubmed: 34874122
doi: 10.1002/ehf2.13722
pmc: PMC8788050
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
476-485Informations de copyright
© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Références
Int J Cardiol. 2009 Mar 6;132(3):354-63
pubmed: 18255178
Eur J Heart Fail. 2017 Jul;19(7):873-879
pubmed: 27860029
Int J Cardiol. 2017 Aug 15;241:318-321
pubmed: 28479093
Heart Fail Rev. 2016 Jan;21(1):65-76
pubmed: 26687372
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
J Am Soc Echocardiogr. 2017 Jan;30(1):59-70.e8
pubmed: 28341032
Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H1004-H1013
pubmed: 27473939
JAMA. 2019 Sep 17;322(11):1077-1084
pubmed: 31475296
J Am Soc Echocardiogr. 2019 Feb;32(2):248-256
pubmed: 30316541
ESC Heart Fail. 2022 Feb;9(1):476-485
pubmed: 34874122
JACC Cardiovasc Imaging. 2020 May;13(5):1107-1115
pubmed: 31954642
Cardiology. 2017;138 Suppl 1:3-6
pubmed: 29262403
Am J Physiol Heart Circ Physiol. 2013 Nov 1;305(9):H1373-81
pubmed: 23997100
Pulm Circ. 2019 Jul-Sep;9(3):2045894019862435
pubmed: 31218910
Am J Cardiol. 2013 Dec 1;112(11):1778-84
pubmed: 24063825
Life (Basel). 2021 Oct 10;11(10):
pubmed: 34685436
Chest. 2015 Jul;148(1):226-234
pubmed: 25633590
Heart Fail Rev. 2021 Nov;26(6):1371-1381
pubmed: 32219615
Circ Heart Fail. 2016 Jul;9(7):
pubmed: 27370069
Circ Cardiovasc Imaging. 2018 Nov;11(11):e007696
pubmed: 30571318
Int J Cardiol. 2019 Dec 1;296:103-108
pubmed: 31324396
Am Heart J. 2009 Jun;157(6):1026-34
pubmed: 19464413
Heart Fail Clin. 2018 Jul;14(3):413-423
pubmed: 29966638
Eur J Heart Fail. 2020 Jul;22(7):1186-1198
pubmed: 32352628
Heart Fail Clin. 2019 Apr;15(2):191-204
pubmed: 30832811
Circ Cardiovasc Imaging. 2018 Jan;11(1):e006894
pubmed: 29321212
J Card Fail. 2012 Mar;18(3):208-15
pubmed: 22385941
Circ Heart Fail. 2016 Apr;9(4):e002763
pubmed: 27056882
JACC Cardiovasc Imaging. 2015 Dec;8(12):1351-1359
pubmed: 26577264
Eur Heart J Cardiovasc Imaging. 2018 Jun 1;19(6):591-600
pubmed: 29596561
Heart Fail Rev. 2020 Nov;25(6):937-948
pubmed: 31617033
Am J Cardiol. 2019 Jul 1;124(1):55-62
pubmed: 31047653
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371
pubmed: 28314623
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
Heart Fail Rev. 2019 Sep;24(5):661-669
pubmed: 31025236
Eur Heart J Cardiovasc Imaging. 2022 Jan 24;23(2):e34-e61
pubmed: 34729586
Diagnostics (Basel). 2020 Nov 13;10(11):
pubmed: 33202837
Circ Cardiovasc Imaging. 2016 Mar;9(3):
pubmed: 26941415